Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rosanne M. Orr
Observed names:
Orr,
R M Orr,
R. Orr,
R.M. ORR,
R.M. Orr,
RM Orr
show all 6
Institutions:
Institute of Cancer Research,
Cancer Research UK
Observed institutions:
Institute of Cancer Research,
Cancer Research UK
OpenAlex ID:
A5113552095
Induction of apoptosis by a novel copper-based anticancer compound, Casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells
2000
·
A. De Vizcaya-Ruiz
, A. Rivero-Muller
, et al.
·
Toxicology in Vitro
·
135
Pharmacokinetics of G3139, a Phosphorothioate Oligodeoxynucleotide Antisense to bcl-2, after Intravenous Administration or Continuous Subcutaneous Infusion to Mice
1997
·
Florence I. Raynaud
, Rosanne M. Orr
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
106
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
2001
·
R M Orr
·
PubMed
·
88
Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: Antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival
2004
·
Jane Renshaw
, Rosanne M. Orr
, et al.
·
Molecular Cancer Therapeutics
·
34
Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
1996
·
P M Goddard
, R M Orr
, et al.
·
PubMed
·
32
Platinum coordination complexes which circumvent cisplatin resistance
1991
·
Ken R. Harrap
, Lloyd R. Kelland
, et al.
·
Advances in Enzyme Regulation
·
21
2'-Deoxycytidine kinase deficiency is a major determinant of 2-chloro-2'-deoxyadenosine resistance in lymphoid cell lines
1995
·
Orr
, Talbot
, et al.
·
PubMed
·
19
Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin
1994
·
RM Orr
, CF O'Neill
, et al.
·
British Journal of Cancer
·
19
PDF
Dinucleotide analogs as inhibitors of thymidine kinase, thymidylate kinase and ribonucleotide reductase
1988
·
Lawrence C. Davies
, John A. Stock
, et al.
·
Journal of Medicinal Chemistry
·
13
Clinical Studies of Antisense Oligonucleotides for Cancer Therapy
2004
·
Rosanne M. Orr
, F. Andrew Dorr
·
Humana Press eBooks
·
7
Oligonucleotide Pharmacology and Formulation: G3139 Anti-BCL2 Phosphorothioate In Stealth® Liposomes and Gel Implants
1997
·
M. C. Woodle
, F. I. Raynaud
, et al.
·
Nucleosides and Nucleotides
·
5
Drug Resistance as a Focus for New Drug Design
1988
·
K.R. HARRAP
, M. JONES
, et al.
·
Elsevier eBooks
·
5
Evaluation of novel platinum (II), and platinum (IV) ammine/amine complexes in L1210 murine leukaemia cell lines sensitive and resistant to cisplatin and tetraplatin
1993
·
Rosanne M. Orr
, C. F. J. Barnard
, et al.
·
4
Synthesis and ribonucleotide reductase inhibitory activity of analogues of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY).
1987
·
A J Goddard
, R M Orr
, et al.
·
PubMed
·
4
Inhibition of human leukaemic thymidylate kinase and L1210 ribonucleotide reductase by dinucleotides of adenosine and thymidine and their phosphonate analogues
1988
·
Rosanne M. Orr
, Lawrence C. Davies
, et al.
·
Biochemical Pharmacology
·
1
Pharmacologic Disposition of a Phosphorothioate Oligodeoxynucleotide in Mice
1997
·
Rosanne M. Orr
, Florence I. Raynaud
, et al.
·
Nucleosides and Nucleotides
Show more works
View as search
Works count:
16
Citation count:
493
H-index:
9
I10-index:
9
Year
Topic
Type
